Drugplain

retaine PM 200 mg/g

Mineral Oil, White petrolatum · OINTMENT · OCuSOFT LLC

No Recall History
Plain English

retaine PM is a ointment containing mineral oil, white petrolatum at 200 mg/g, taken ophthalmic. Manufactured by OCuSOFT LLC.

Key Facts

Brand Name
retaine PM
Generic Name
Mineral Oil, White petrolatum
NDC Code (Product)
54799-893
Manufacturer
OCuSOFT LLC
Strength
200 mg/g
Dosage Form
OINTMENT
Route
OPHTHALMIC
Marketing Status
Application #
M018
Marketing Start
09/02/2013

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

eye pain37 reports
eye irritation13 reports
photophobia12 reports
eye swelling10 reports
ocular hyperaemia9 reports
foreign body sensation in eyes8 reports
vision blurred8 reports
wrong technique in product usage process8 reports
dry eye7 reports
eyelid pain7 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses As a lubricant to prevent further irritaion or to relieve dryness of the eye(s).

Dosage & Administration

Directions ● Pull down the lower lid of the affected eye(s). ● Apply a small amount (1/4 inch) of ointment to the inside of the eyelid.

Warnings

Warnings For use in the eyes only.

Frequently Asked Questions

What is retaine PM used for?

retaine PM contains Mineral Oil, White petrolatum. It is a ointment taken ophthalmic. Consult your doctor for specific uses.

Is retaine PM a controlled substance?

retaine PM is not classified as a controlled substance by the DEA.

What is the generic name for retaine PM?

The generic name for retaine PM is Mineral Oil, White petrolatum. There are 3 other brand versions of Mineral Oil, White petrolatum.

What is the NDC code for retaine PM 200 mg/g?

The NDC (National Drug Code) for retaine PM 200 mg/g is 54799-893, listed by OCuSOFT LLC.

Product NDC

54799-893

Package NDC

54799-893-05

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)